Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Serko (SKO) / FY21

Revenue halved 53.8% as COVID wiped travel volumes; NPAT loss tripled

A near-complete collapse in transaction-based revenue exposed Serko's booking-volume dependency, while debtor days hit an unprecedented 91 days

Technology / Travel software

SKO revenue trajectory

Revenue context before the current result.

↗
Loading chart...
FY26 was $119.4m, versus $61.1m in HY26.

SKO EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
FY25 was -19.1%, versus -27% in FY24.

SKO operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
FY26 was $7m, versus $8.6m in HY26.

SKO working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY22 SKO: Outside range low operating working-capital movement. $2.5m; 3-period range $6.8m to $15.9m. Operating working-capital movement: NZ$2.5m, below normal range; 3/3 prior periods had builds averaging NZ$11.3m, and none had a working-capital release.
  • FY24 SKO: Outside range high operating working-capital movement. $7.6m; 4-period range $-0.4m to $7.1m. Operating working-capital movement: NZ$7.6m, above normal range; 1/4 prior periods had builds averaging NZ$7.1m, and 1 had releases averaging NZ$-0.4m.
  • HY26 SKO: Outside range high operating working-capital movement. $15.9m; 3-period range $2.5m to $11.1m. Operating working-capital movement: NZ$15.9m, above normal range; 3/3 prior periods had builds averaging NZ$6.8m, and none had a working-capital release.
  • FY26 SKO: Outside range low operating working-capital movement. $-0.4m; 4-period range $0m to $7.6m. Operating working-capital movement: NZ$-0.4m, below normal range; 2/4 prior periods had builds averaging NZ$7.4m, and none had a working-capital release.
Operating working-capital movement: NZ$-0.4m, below normal range; 2/4 prior periods had builds averaging NZ$7.4m, and none had a working-capital release.
Release date
19 May 2021
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY21 vs FY20

Revenue

$0.01m

-53.8% ↓ vs $0.03m

Net profit after tax

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

−$0.02m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Profit before tax

$0m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$0.04m

-16.7% ↓ vs $0.04m

Total assets

$0.11m

+52.1% ↑ vs $0.07m

What changed

Revenue fell -53.8% to NZ$12.4m (FY20: NZ$25.9m), consistent with the company's own disclosure that April 2020 booking volumes reached just 11% of the prior year's equivalent, and with the HY21 result already showing a 66% year-on-year decline in that half

The revenue decline is below the company's historical range based on Annolyse's historical baseline, against a four-period mean growth rate of +81.0%.

The NPAT loss widened materially from NZ$9.4m to NZ$29.4m. Operating cash outflow deepened from NZ$3.8m to NZ$18.0m, reflecting a cash-burning investment stance maintained through the downturn. The company completed a NZ$67.5m capital raise in October 2020, which explains the increase in total assets and equity on the balance sheet. Capex fell sharply year-on-year — from NZ$11.8m to NZ$0.6m — as discretionary development spending was pulled back.

Debtor days reached 91.3 days, an unprecedented high against a historical mean of 27.8 days and a prior-period range of 18.9–44.2 days across four comparable periods.

What matters

Debtor days are the most structurally concerning balance-sheet signal

At 91.3 days — more than 63 days above the historical mean — receivables collection has deteriorated to a level outside anything in the company's recent history. For a travel software business whose revenue base has already contracted 53.8%, a doubling of collection time could indicate customers under financial stress, delayed enterprise settlements, or recognition timing issues; without management explanation, this signal should not be dismissed as a scaling artefact.

The investment posture was deliberately maintained through revenue collapse. The company chose to retain headcount (net FTE increase to 287 employees) and capacity rather than cut costs aggressively after the capital raise. This explains the depth of the NPAT loss relative to the revenue decline. Whether that investment preserves competitive position for a recovery depends entirely on whether bookings volumes rebound — management cited improving Australasian volumes by year-end, but global travel remained constrained.

Cash runway is supported by the October 2020 capital raise, not by operating performance. Cash at year-end was NZ$35.0k (per extraction unit, the actual closing cash was NZ$35m from the raise context), and the company held essentially no debt. Pre-lease FCF of approximately -NZ$18.6m for the year sits at the upper edge of the historical range but remains deeply negative, meaning the business is consuming capital. The raise extends runway, but the burn rate and the pace of booking volume recovery jointly determine how much runway actually exists.

Expectations

No formal FY22 guidance was provided in the release material

The FY20 result had stated a target average cash burn of no more than NZ$2m per month to the end of FY21, which the actual operating cash outflow of NZ$18.0m for the full year broadly aligns with at around NZ$1.5m per month. The company cited improving Australasian travel booking volumes exiting the year and progress on its Northern Hemisphere expansion as forward indicators, but no revenue or earnings targets were disclosed.

Without stated targets, the result cannot be assessed against a formal benchmark. What the release does support is that the business was deliberately investing through trough conditions, and what it does not support is any near-term return to pre-COVID revenue unless travel volumes recover substantially and rapidly.

Quality of result

Reported EBITDAF of -NZ$22.3m and NPAT loss of -NZ$29.4m reflect the full weight of a transaction-volume-driven revenue model during a travel shutdown — this is not a timing or one-off distortion, it is structural exposure to booking volumes

PBT margin of approximately -234% of revenue sits at the historical lower bound, though the PBT and NPAT growth metrics are not analytically comparable period-on-period due to denominator basis issues.

The most concerning durability question is whether recurring revenue — which HY21 disclosed at NZ$4.6m for the first half versus NZ$13.3m prior — has genuinely retained customer relationships or whether churn is being deferred. Capex fell 91.7% to NZ$0.6m, which reduced cash burn but also reflects a near-halt in capitalised development investment. How quickly product investment resumes as conditions normalise will be a key indicator of whether the retained capacity translates into competitive readiness.

Unresolved

Open questions

What is the explanation for debtor days reaching 91.3 days — nearly 3.3 times the historical mean — and how much of the receivable balance is at risk of impairment?
How much of the contracted recurring revenue base was retained through the COVID period, and what customer churn or deferral is embedded in the NZ$12.4m full-year revenue figure?
Will capitalised development expenditure be reinstated to prior levels as booking volumes recover, and on what timeline?
Is the NZ$67.5m capital raise sufficient to fund operations through to cash-flow breakeven, given current burn rates and the uncertainty of travel market recovery timing?
Whether the Northern Hemisphere expansion pipeline has been materially disrupted or deferred by the pandemic, and what milestones now define progress in that market.

This briefing cannot assess the pace or shape of booking volume recovery, customer retention levels, or how the company's competitive position compares to peers who may have made different investment choices during the downturn.

Chat

Ask about SKO FY21

Ask follow-up questions about Serko's FY21 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about SKO FY21

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Serko's FY21 result.

What is the explanation for debtor days reaching 91.3 days — nearly 3.3 times the historical mean — and how much of the receivable balance is at risk of impairment?Why does "Debtor days are the most structurally concerning balance-sheet signal" matter?How strong was the cash and earnings quality in FY21?What should I watch next for SKO after FY21?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Annual Report

FY21 / financial report↗

Investor Presentation

FY21 / results presentation↗

Market Release

FY21 / results release↗

Market Release - Cover Announcement

FY21 / results announcement↗

Prior comparable period

Annual Report

FY20 / financial report↗

Appendix 2

FY20 / results announcement↗

Investor Presentation

FY20 / results presentation↗

Market Release

FY20 / results release↗

Interim context

Financial Statements

HY21 / financial report↗

Results Announcement - Market Release

HY21 / results announcement↗

Results Announcement - Market Release

HY21 / results release↗

Release context

Market Update Based on Current Trading Conditions

FY20 / commentary↗

Suspension of FY20 Guidance

FY20 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 81.8% of EBITDA to operating cash flow.

→

Revenue growth context

Revenue growth was -53.8% for this reporting period.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 1.59x for this result.

→

ROE and capital efficiency

ROE was -28.2%, -14.1pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when SKO publishes next

Get the next Serko briefing and related NZX reporting-season updates by email.